Physician profile
Michael P Lilly
NPI 1700887916
$4,441.64
in general payments reported to CMS, 2019-2025
12 companies · $947 in 2025
The $947 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $2,500 · 2022: $151 · 2023: $226 · 2024: $341 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,500.00 | 2020 | |
| W. L. Gore & Associates, INC. | $1,065.03 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Endologix LLC | $279.45 | 2025 | Alto Abdominal Stent Graft System |
| Cook Medical LLC | $165.03 | 2025 | Zenith, Zilver Ptx |
| Sanara Medtech INC. | $149.87 | 2024 | Celleraterx |
| Abbott Laboratories | $109.78 | 2025 | Esprit |
| Silk Road Medical, INC. | $57.42 | 2019 | |
| Integra Lifesciences Corporation | $33.51 | 2019 | |
| Kci USA, INC. | $24.20 | 2023 | Prevena |
| Boston Scientific Corporation | $23.12 | 2023 | |
| Tactile Systems Technology INC | $21.55 | 2024 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.